Log in to save to my catalogue

Clinical utility of circulating tumor DNA sequencing with a large panel in patients with advanced so...

Clinical utility of circulating tumor DNA sequencing with a large panel in patients with advanced so...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_159023a74aaa4424a218e1fc639d880e

Clinical utility of circulating tumor DNA sequencing with a large panel in patients with advanced soft‐tissue sarcomas

About this item

Full title

Clinical utility of circulating tumor DNA sequencing with a large panel in patients with advanced soft‐tissue sarcomas

Publisher

United States: John Wiley & Sons, Inc

Journal title

Cancer communications (London, England), 2023-09, Vol.43 (9), p.1051-1054

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Abbreviations ctDNA circulating tumor DNA CNV copy number variation ESCAT European Society of Medical Oncology Scale for Clinical Actionability of molecular Targets MTB molecular tumor board NGS next-generation sequencing OS overall survival PFS progression-free survival STS soft-tissue sarcomas To the editor Soft-tissue sarcomas (STS) represent a...

Alternative Titles

Full title

Clinical utility of circulating tumor DNA sequencing with a large panel in patients with advanced soft‐tissue sarcomas

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_159023a74aaa4424a218e1fc639d880e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_159023a74aaa4424a218e1fc639d880e

Other Identifiers

ISSN

2523-3548

E-ISSN

2523-3548

DOI

10.1002/cac2.12461

How to access this item